Innovating against malaria
Our news
GSK’s malaria candidate vaccine, Mosquirix™ (RTS,S), receives positive opinion from European regulators for the prevention of malaria in young children in sub-Saharan Africa
GSK and Save the Children launch 2015 call for developing country healthcare innovations to reduce child deaths
GSK and the Francis Crick Institute join forces in collaboration to forge new scientific discoveries
To challenge. To change.
Join the conversation
Tweets from GSK
-
Moncef, our vaccines chairman, talks to @qzafrica about the 30-year search for a #malaria vaccine: gsk.to/1GL2u6Y #fightmalaria
5 hours ago
Explore our products
We make a wide range of prescription medicines, prescribed vaccines and consumer healthcare products.
Working at GSK
Information for investors
Corporate reporting
